Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY)
Aim. To perform a pharmacoeconomical assessment of the use of generic statin drugs in patients with high and very high cardiovascular risk (CVR) in real clinical practice based on the data of the study PRIORITY.Material and methods. The PRIORITY study included 298 patients with high (29; 9.7%) and v...
Saved in:
| Main Authors: | S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2020-11-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/2302 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study)
by: S. Yu. Martsevich, et al.
Published: (2019-01-01) -
ECONOMIC REASONS FOR GENERIC CHOICE
by: N. P. Kutishenko, et al.
Published: (2016-01-01) -
THE EFFECTIVENESS OF OUTPATIENT AND HOSPITAL LIPID-LOWERING THERAPY IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK DURING 2011-2015
by: S. A. Smetnev, et al.
Published: (2017-01-01) -
Efficacy and safety of combination therapy Ezetimibe 10/rosuvastatin 40 in Egyptian patients at very high risk of atherosclerotic cardiovascular disease
by: Mohamed Sobhy, et al.
Published: (2025-06-01) -
The problem of choice: original drug or generic? Emphasis on rosuvastatin
by: O. A. Polyakova, et al.
Published: (2022-05-01)